Last reviewed · How we verify

NCT06052501

3D Evaluation of the Lip Support in a Full-arch Implant-supported Rehabilitations

Recruiting now Last updated 26 June 2024
What this trial tests

trial testing Removable of the full arch implant-supported prostheses in Digital Technology in 20 participants. Currently enrolling.

Timeline
30 March 2024
Primary endpoint
15 June 2024
15 December 2024

Quick facts

Lead sponsorImplantology Institute
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment20
Start date30 March 2024
Primary completion15 June 2024
Estimated completion15 December 2024
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Implantology Institute

Who can join

Eligibility, any sex, with Digital Technology or Prosthesis User. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to evaluate the impact of a full arch implant-supported prostheses in the lip support. In a complex rehabilitation cases, the process between the diagnosis and the delivery of a prostheses may lead with many clinical and laboratorial choices which influence the final design of the prosthetic work and consequently the facial profile of the patient. The use of 3D facial scanners and advanced superimposition methodology allows the investigators to objectively measure several relevant parameters such as vertical occlusion of dimension and lip support.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Digital Technology

Currently open trials in the same condition.

Other Implantology Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06052501.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing